Abbott | ABT - Sales Revenues


Abbott reported $12.59B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Agilent USD 1.84B 37M Mar/2026
AtriCure USD 141.2M 700K Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Bio-Rad Laboratories USD 592.1M 101.1M Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Cooper Companies USD 1.08B 57.4M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Dexcom USD 1.19B 70M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Globus Medical USD 759.85M 66.55M Mar/2026
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
Intuitive Surgical USD 2.89B 120M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Medtronic USD 9.8B 800M Mar/2026
Merit Medical Systems USD 381.9M 12M Mar/2026
Pfizer USD 14.5B 3.08B Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025
Solventum Corp USD 2.01B 20M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Tandem Diabetes Care USD 247.22M 43.18M Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
Terumo JPY 300.32B 3.69B Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026